In light of the key announcement made by the company on May 24, it could be a good time for investors to consider tracking the Pacific Software Inc. (OTC:PFSF) stock this morning. The company announced at the time that it had been successful in completing the acquisition of a science-backed dietary supplement aimed at aiding memory function and brain health.
In this context, it ought to be noted that the supplement in question has been sold in a profitable manner for more than 8 years under the brand names A L Z Defense and SuppleMEM AD. The formula for the product had also been thoroughly tested by researchers involved in Alzheimer’s disease. Harrysen Mittler, the Chief Executive Officer of Pacific Software, spoke about the latest move from the company. He noted that the new acquisition added a new product line that could help Pacific Software with a faster path to profitability and also expanded the scope of the company. He went on to note that previously, the company had only been involved in wound healing and skin care.
It should be noted that the core formula of the A L Z Defense product consisted of a combination of safe natural products along with a ‘medical food cocktail’. The cocktail in question had been created in order to boost some of the vital constituents of memory, like neuroplasticity.
The company also noted that the evaluation of the formula had been concluded in two lab experiments running over several years and had been financed through a research grant from the NIH (National Institute of Health). The first of those studies was conducted at the University of California, Irvine, and the second was conducted at the University of Kentucky. It could be a good idea to keep an eye on the Pacific Software stock this morning.
